Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Vaccine ; 18(19): 1982-93, 2000 Apr 03.
Article in English | MEDLINE | ID: mdl-10706959

ABSTRACT

The stability and integrity of glycoconjugate vaccines requires determination of the total saccharide and quantification of the unbound or free saccharide present. The traditional assay for Hib conjugates, based on colorimetric determination of ribose, has been much improved by the use of base hydrolysis and analysis of the Hib subunit generated using high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD). The production of this subunit was confirmed by NMR analysis. However, quantification of free Hib saccharide using this method was not possible in the combination vaccines evaluated due to interferences emanating from DPT. Thus a method based on TFA hydrolysis followed by the chromatographic separation and quantification of ribitol on a CarboPac MA1 column was developed. The method is selective, and with the use of ED40 electrode, requires only nanomole amounts for the chromatographic step, thereby ensuring that free saccharide can be monitored accurately in the formulated Hib-CRM vaccine alone and when in combination with other vaccines.


Subject(s)
Carbohydrates/analysis , Diphtheria-Tetanus-Pertussis Vaccine/analysis , Haemophilus Vaccines/analysis , Vaccines, Combined/analysis , Chromatography, Ion Exchange/methods , Evaluation Studies as Topic , Humans , Hydrolysis , Magnetic Resonance Spectroscopy , Ribitol/analysis , Vaccines, Conjugate/analysis
2.
Vaccine ; 17(22): 2802-16, 1999 Jul 16.
Article in English | MEDLINE | ID: mdl-10438050

ABSTRACT

We recently described the use of ion exchange chromatography for analysis and the industrial scale preparation of pools of oligosaccharides of intermediate chain length from polysaccharides of Haemophilus influenzae type b (Hib) and Neisseria meningitidis groups A and C. These negatively charged "sized" oligosaccharides are activated and conjugated to the carrier protein (CRM197) to prepare the corresponding glycoconjugate vaccines. Characterization and accurate determination of the degree of polymerization (DP) of the pool of oligosaccharides is essential for the consistent production of these conjugate vaccines. This paper describes the colorimetric assays used for determination of the average DP of the Hib and meningococcal oligosaccharides, and the qualification of these assays achieved by size characterization of the respective oligosaccharides by use of physicochemical methods, including liquid chromatography, mass spectrometry (ionspray) and NMR spectroscopy.


Subject(s)
Bacterial Capsules/chemistry , Bacterial Vaccines/metabolism , Oligosaccharides/isolation & purification , Bacterial Capsules/immunology , Bacterial Outer Membrane Proteins/analysis , Bacterial Outer Membrane Proteins/immunology , Bacterial Outer Membrane Proteins/isolation & purification , Bacterial Vaccines/therapeutic use , Chromatography, Liquid , Colorimetry , Haemophilus Vaccines/analysis , Haemophilus Vaccines/immunology , Haemophilus Vaccines/isolation & purification , Haemophilus influenzae type b/immunology , Humans , Mass Spectrometry , Meningitis/prevention & control , Meningitis, Meningococcal/prevention & control , Molecular Weight , Neisseria meningitidis/immunology , Nuclear Magnetic Resonance, Biomolecular , Oligosaccharides/analysis , Oligosaccharides/immunology , Polysaccharides, Bacterial/analysis , Polysaccharides, Bacterial/immunology , Polysaccharides, Bacterial/isolation & purification , Vaccines, Conjugate/analysis , Vaccines, Conjugate/immunology , Vaccines, Conjugate/isolation & purification
3.
Vaccine ; 17(9-10): 1251-63, 1999 Mar 05.
Article in English | MEDLINE | ID: mdl-10195638

ABSTRACT

We have developed a chromatographic method suitable for the fractionation of polysaccharides having a negatively charged group. The method permits the removal of all those polysaccharide fragments having a short sequence and which are likely unsuitable for conjugate vaccine construction. The selected polysaccharide fragments can be used to produce glycoconjugate vaccines containing a restricted saccharide polydispersion. We have applied this chromatographic method to three different antigens, Haemophilus influenzae type b and Neisseria meningitidis group A and group C polysaccharides. The method is easily adapted for manufacturing purposes.


Subject(s)
Antigens, Bacterial/chemistry , Bacterial Capsules/chemistry , Haemophilus Vaccines/chemistry , Polysaccharides, Bacterial/chemistry , Vaccines, Conjugate/chemistry , Chromatography, Ion Exchange , Enzyme-Linked Immunosorbent Assay , Hydrolysis , Mass Spectrometry , Neisseria meningitidis , Ultrafiltration
SELECTION OF CITATIONS
SEARCH DETAIL
...